EP Patent
EP2440183A4 — ENHANCED LIPID FORMULATION
Assigned to Arbutus Biopharma Corp · Expires 2013-02-27 · 13y expired
What this patent protects
Patent listed against Onpattro.
Drugs covered by this patent
- Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.